Hopkinson Craig C.
Insider transactions at 1 company
This page shows all SEC Form 4 filings attributed to Hopkinson Craig C.. Form 4 disclosures are required whenever a corporate insider — director, officer, or 10%+ shareholder — buys, sells, or receives company stock. Each row represents a separate reported transaction. All data is sourced directly from the SEC EDGAR public database.
| Company | Title | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| ALKS | EVP R&D, Chief Medical Officer | Sale | 3,748 | $30.00 | $112,440 | Dec 3, 2025 |
| ALKS | EVP R&D, Chief Medical Officer | Sale | 4,000 | $29.30 | $117,200 | Dec 1, 2025 |
| ALKS | EVP R&D, Chief Medical Officer | Option Exercise | 5,000 | $19.34 | $96,700 | Nov 3, 2025 |
| ALKS | EVP R&D, Chief Medical Officer | Sale | 9,000 | $31.53 | $283,770 | Oct 15, 2025 |
| ALKS | EVP R&D, Chief Medical Officer | Option Exercise | 6,866 | — | — | Feb 26, 2025 |
| ALKS | EVP R&D, Chief Medical Officer | Tax Withholding | 5,452 | $35.32 | $192,565 | Feb 22, 2025 |
| ALKS | EVP R&D, Chief Medical Officer | Tax Withholding | 3,950 | $35.90 | $141,805 | Feb 18, 2025 |
| ALKS | EVP R&D, Chief Medical Officer | Sale | 33,108 | $33.27 | $1,101,503 | Feb 12, 2025 |
| ALKS | EVP R&D, Chief Medical Officer | Award / Grant | 34,393 | — | — | Feb 6, 2025 |
| ALKS | EVP R&D, Chief Medical Officer | Option Exercise | 29,156 | $20.03 | $583,995 | Jan 30, 2025 |
| ALKS | EVP R&D, Chief Medical Officer | Option Exercise | 12,452 | $20.03 | $249,414 | Dec 9, 2024 |
| ALKS | EVP R&D, Chief Medical Officer | Sale | 9,221 | $31.50 | $290,462 | Dec 5, 2024 |
| ALKS | EVP R&D, Chief Medical Officer | Sale | 14,349 | $30.77 | $441,519 | Dec 4, 2024 |
| ALKS | EVP R&D, Chief Medical Officer | Sale | 58,996 | $30.08 | $1,774,600 | Nov 11, 2024 |
| ALKS | EVP R&D, Chief Medical Officer | Sale | 10,471 | $29.53 | $309,209 | Nov 6, 2024 |
| ALKS | EVP R&D, Chief Medical Officer | Tax Withholding | 3,414 | $29.57 | $100,952 | Feb 23, 2024 |
| ALKS | EVP R&D, Chief Medical Officer | Option Exercise | 12,278 | — | — | Feb 22, 2024 |
| ALKS | EVP R&D, Chief Medical Officer | Option Exercise | 10,297 | — | — | Feb 18, 2024 |
| ALKS | EVP R&D, Chief Medical Officer | Tax Withholding | 15,280 | $26.77 | $409,046 | Feb 8, 2024 |
| ALKS | EVP R&D, Chief Medical Officer | Tax Withholding | 5,345 | $27.77 | $148,431 | Feb 22, 2023 |
| ALKS | EVP R&D, Chief Medical Officer | Tax Withholding | 6,526 | $28.07 | $183,185 | Feb 20, 2023 |
| 0001322505 | Award / Grant | 10,495 | — | — | Dec 1, 2022 | |
| ALKS | EVP R&D, Chief Medical Officer | Sale | 11,983 | $24.76 | $296,699 | Feb 23, 2022 |
| ALKS | EVP R&D, Chief Medical Officer | Sale | 2,306 | $25.17 | $58,042 | Feb 20, 2022 |
| ALKS | EVP R&D, Chief Medical Officer | Tax Withholding | 1,069 | $26.79 | $28,639 | Feb 16, 2022 |
| ALKS | EVP R&D, Chief Medical Officer | Tax Withholding | 5,647 | $30.60 | $172,798 | Sep 14, 2021 |
| ALKS | EVP R&D, Chief Medical Officer | Sale | 882 | $24.60 | $21,697 | Jun 9, 2021 |
| ALKS | EVP R&D, Chief Medical Officer | Option Exercise | 1,250 | — | — | Jun 7, 2021 |
| ALKS | EVP R&D, Chief Medical Officer | Sale | 28,920 | $19.72 | $570,302 | Apr 15, 2021 |
| ALKS | EVP R&D, Chief Medical Officer | Option Exercise | 6,875 | — | — | Feb 21, 2021 |
| ALKS | EVP R&D, Chief Medical Officer | Tax Withholding | 1,172 | $19.79 | $23,194 | Feb 16, 2021 |
| ALKS | EVP R&D, Chief Medical Officer | Option Exercise | 1,250 | — | — | Jun 7, 2020 |
| ALKS | EVP R&D, Chief Medical Officer | Option Exercise | 6,875 | — | — | Feb 21, 2020 |
| ALKS | EVP R&D, Chief Medical Officer | Tax Withholding | 2,004 | $20.24 | $40,561 | Feb 21, 2020 |
| ALKS | EVP R&D, Chief Medical Officer | Option Exercise | 3,375 | — | — | Feb 16, 2020 |
| ALKS | SVP, Med Dev/Med Affairs, CMO | Tax Withholding | 368 | $22.83 | $8,401 | Jun 7, 2019 |
| ALKS | SVP, Med Dev/Med Affairs, CMO | Tax Withholding | 1,083 | $32.54 | $35,241 | Feb 16, 2019 |
| ALKS | SVP, Med Dev/Med Affairs, CMO | Award / Grant | 4,000 | — | — | Dec 7, 2018 |
| ALKS | SVP, Med Dev/Med Affairs, CMO | Option Exercise | 1,250 | — | — | Jun 7, 2018 |